Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Anthera's Lead Drug: A High-Risk, High-Reward Proposition
Anthera's Lead Drug: A High-Risk, High-Reward Proposition
Anthera's Lead Drug: A High-Risk, High-Reward Proposition
Submitted by
admin
on June 27, 2010 - 11:04am
Source:
Seeking Alpha
News Tags:
Anthera
A-002
acute coronary syndrome
GSK
darapladib
Headline:
Anthera's Lead Drug: A High-Risk, High-Reward Proposition
Do Not Allow Advertisers to Use My Personal information
